Current Protein Identity:Q9H2S1 New Search
Main Difference Dimensions in This Set
Different construct Different mutation/modification Different assembly state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics

Difference tags compare only the current result set; every original PDB and assembly record remains separate.

Related-Structure Differences

Each row represents one biological assembly in one PDB entry; multiple monomers of the same protein are listed separately.

PDB Entry Assembly / Oligomeric State Construct Mutations and Modifications Ligands, Ions and Non-polymers Experimental Method Experimental Conditions Structure Quality
5V02 A positive allosteric modulator binding pocket in SK2 ion channels is shared by Riluzole and CyPPA Deposited 2017-02-28 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain B 395–486(92 aa) Fragment:UNP residues 395-486
Not recorded SO4 SULFATE ION × 2 657 6-(trifluoromethoxy)-1,3-benzothiazol-2-amine × 1 GOL GLYCEROL × 1 CA CALCIUM ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;295 K;ammonia sulfate
Resolution 1.78 Å R-free 0.215
5V03 A positive allosteric modulator binding pocket in SK2 ion channels is shared by Riluzole and CyPPA Deposited 2017-02-28 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain B 395–486(92 aa) Fragment:UNP residues 395-486
Not recorded SO4 SULFATE ION × 1 658 N-(4-chlorophenyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-amine × 1 CA CALCIUM ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;295 K;ammonia sulfate
Resolution 1.58 Å R-free 0.220
5WBX Structural insights into the potency of SK/IK channel positive modulators Deposited 2017-06-29 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain B 395–486(92 aa)
Mutation:N407A SO4 SULFATE ION × 4 GOL GLYCEROL × 2 CA CALCIUM ION × 2 AJY (3Z)-6-bromo-3-(hydroxyimino)-5-methyl-1,3-dihydro-2H-indol-2-one × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 5.8;293.15 K;0.1 M Sodium itrate tribasic dihydrate 0.5 M Ammonium sulfate 1.5 M Lithium sulfate monohydrate
Resolution 1.90 Å R-free 0.243
5WBX Structural insights into the potency of SK/IK channel positive modulators Deposited 2017-06-29 Assembly 2 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain B 395–486(92 aa)
Mutation:N407A SO4 SULFATE ION × 8 GOL GLYCEROL × 4 CA CALCIUM ION × 4 AJY (3Z)-6-bromo-3-(hydroxyimino)-5-methyl-1,3-dihydro-2H-indol-2-one × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 5.8;293.15 K;0.1 M Sodium itrate tribasic dihydrate 0.5 M Ammonium sulfate 1.5 M Lithium sulfate monohydrate
Resolution 1.90 Å R-free 0.243
5WC5 Structural insights into the potency of SK/IK channel positive modulators Deposited 2017-06-29 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain B 395–486(92 aa)
Mutation:N407A SO4 SULFATE ION × 6 GOL GLYCEROL × 1 CA CALCIUM ION × 2 AJV 7-fluoro-3-(hydroxyamino)-2H-indol-2-one × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 5.8;293.15 K;0.1 M Sodium citrate tribasic dihydrate 0.5 M Ammonium sulfate 1.5 M Litium sulfate monohydrate
Resolution 2.30 Å R-free 0.250
5WC5 Structural insights into the potency of SK/IK channel positive modulators Deposited 2017-06-29 Assembly 2 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain B 395–486(92 aa)
Mutation:N407A SO4 SULFATE ION × 12 GOL GLYCEROL × 2 CA CALCIUM ION × 4 AJV 7-fluoro-3-(hydroxyamino)-2H-indol-2-one × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 5.8;293.15 K;0.1 M Sodium citrate tribasic dihydrate 0.5 M Ammonium sulfate 1.5 M Litium sulfate monohydrate
Resolution 2.30 Å R-free 0.250
6ALE A V-to-F substitution in SK2 channels causes Ca2+ hypersensitivity and improves locomotion in a C. elegans ALS model Deposited 2017-08-07 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain B 394–486(93 aa) Fragment:calmodulin binding domain (UNP residues 394-486)
Not recorded SO4 SULFATE ION × 4 1KP (3E)-6,7-dichloro-3-(hydroxyimino)-1,3-dihydro-2H-indol-2-one × 1 GOL GLYCEROL × 1 CA CALCIUM ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 5.6;293.15 K;0.1 M Sodium Citrate Tribasic dehydrate 0.6 M Ammonium sulfate 1.4 M Lithium sulfate monohydrate
Resolution 2.50 Å R-free 0.255
9O48 Cryo-EM structure of the human SK2-4 chimera/calmodulin channel complex in the Ca2+ bound state Deposited 2025-04-08 Assembly 1 Insufficient information Heteromer;Protein × 8 PDB declaration: octameric(8) Consistent with protein count
Chain A 124–412(289 aa) Fragment:SK4 residues 1-15 + SK2 residues 124-412 + SK4 residues 306-428
Chain B 124–412(289 aa) Fragment:SK4 residues 1-15 + SK2 residues 124-412 + SK4 residues 306-428
Chain C 124–412(289 aa) Fragment:SK4 residues 1-15 + SK2 residues 124-412 + SK4 residues 306-428
Chain D 124–412(289 aa) Fragment:SK4 residues 1-15 + SK2 residues 124-412 + SK4 residues 306-428
Not recorded K POTASSIUM ION × 2 CA CALCIUM ION × 16 ELECTRON MICROSCOPY
cryo-EM buffer pH 8;20 mM Tris pH 8, 150 mM KCl, 2 mM CaCl2, 0.005% GDN, 0.0005% CHS
cryo-EM vitrification conditions Cryogen ETHANE;5 uL of sample was applied to grids at 4 degree temperature with 100% humidity. After 30 seconds, grids were blotted for 5 seconds with blot force 25 and plunged into liquid ethane.
Resolution 3.10 Å
9O51 Cryo-EM structure of the human SK2-4 chimera/calmodulin channel complex in the Ca2+ free state Deposited 2025-04-09 Assembly 1 Insufficient information Heteromer;Protein × 8 PDB declaration: octameric(8) Consistent with protein count
Chain A 124–412(289 aa) Fragment:SK4 residues 1-15 + SK2 residues 124-412 + SK4 residues 306-428
Chain B 124–412(289 aa) Fragment:SK4 residues 1-15 + SK2 residues 124-412 + SK4 residues 306-428
Chain C 124–412(289 aa) Fragment:SK4 residues 1-15 + SK2 residues 124-412 + SK4 residues 306-428
Chain D 124–412(289 aa) Fragment:SK4 residues 1-15 + SK2 residues 124-412 + SK4 residues 306-428
Not recorded K POTASSIUM ION × 2 CA CALCIUM ION × 4 ELECTRON MICROSCOPY
cryo-EM buffer pH 8;20 mM Tris pH 8, 150 mM KCl, 5 mM EGTA, 0.005% GDN, 0.0005% CHS
cryo-EM vitrification conditions Cryogen ETHANE;5 uL of sample was applied to grids at 4 degree temperature with 100% humidity. After 30 seconds, grids were blotted for 5 seconds with blot force 25 and plunged into liquid ethane.
Resolution 3.40 Å
9O52 Cryo-EM structure of the human SK2-4 chimera/calmodulin channel complex bound to the bee toxin apamin Deposited 2025-04-09 Assembly 1 Insufficient information Heteromer;Protein × 9 PDB declaration: nonameric(9) Consistent with protein count
Chain A 124–412(289 aa) Fragment:SK4 residues 1-15 + SK2 residues 124-412 + SK4 residues 306-428
Chain B 124–412(289 aa) Fragment:SK4 residues 1-15 + SK2 residues 124-412 + SK4 residues 306-428
Chain C 124–412(289 aa) Fragment:SK4 residues 1-15 + SK2 residues 124-412 + SK4 residues 306-428
Chain D 124–412(289 aa) Fragment:SK4 residues 1-15 + SK2 residues 124-412 + SK4 residues 306-428
Not recorded K POTASSIUM ION × 4 CA CALCIUM ION × 16 ELECTRON MICROSCOPY
cryo-EM buffer pH 8;20 mM Tris pH 8, 150 mM KCl, 2 mM CaCl2, 0.005% GDN, 0.0005% CHS
cryo-EM vitrification conditions Cryogen ETHANE;5 uL of sample was applied to grids at 4 degree temperature with 100% humidity. After 30 seconds, grids were blotted for 5 seconds with blot force 25 and plunged into liquid ethane.
Resolution 3.18 Å
9O53 Cryo-EM structure of the human SK2-4 chimera/calmodulin channel complex bound to a small molecule inhibitor Deposited 2025-04-09 Assembly 1 Insufficient information Heteromer;Protein × 8 PDB declaration: octameric(8) Consistent with protein count
Chain A 124–412(289 aa) Fragment:SK4 residues 1-15 + SK2 residues 124-412 + SK4 residues 306-428
Chain B 124–412(289 aa) Fragment:SK4 residues 1-15 + SK2 residues 124-412 + SK4 residues 306-428
Chain C 124–412(289 aa) Fragment:SK4 residues 1-15 + SK2 residues 124-412 + SK4 residues 306-428
Chain D 124–412(289 aa) Fragment:SK4 residues 1-15 + SK2 residues 124-412 + SK4 residues 306-428
Not recorded A1B8D N-(2,1,3-benzoxadiazol-4-yl)-3-(4-methoxybenzene-1-sulfonamido)benzamide × 4 K POTASSIUM ION × 4 CA CALCIUM ION × 16 ELECTRON MICROSCOPY
cryo-EM buffer pH 8;20 mM Tris pH 8, 150 mM KCl, 2 mM CaCl2, 0.005% GDN, 0.0005% CHS
cryo-EM vitrification conditions Cryogen ETHANE;5 uL of sample was applied to grids at 4 degree temperature with 100% humidity. After 30 seconds, grids were blotted for 5 seconds with blot force 25 and plunged into liquid ethane.
Resolution 3.30 Å
9O5O Cryo-EM structure of the human SK2-4 chimera/calmodulin channel complex bound to a small molecule activator Deposited 2025-04-10 Assembly 1 Insufficient information Heteromer;Protein × 8 PDB declaration: octameric(8) Consistent with protein count
Chain A 124–412(289 aa) Fragment:SK4 residues 1-15 + SK2 residues 124-412 + SK4 residues 306-428
Chain B 124–412(289 aa) Fragment:SK4 residues 1-15 + SK2 residues 124-412 + SK4 residues 306-428
Chain C 124–412(289 aa) Fragment:SK4 residues 1-15 + SK2 residues 124-412 + SK4 residues 306-428
Chain D 124–412(289 aa) Fragment:SK4 residues 1-15 + SK2 residues 124-412 + SK4 residues 306-428
Not recorded A1B8G N-(2,1,3-benzoxadiazol-4-yl)-4-(trifluoromethyl)benzamide × 4 K POTASSIUM ION × 2 CA CALCIUM ION × 16 ELECTRON MICROSCOPY
cryo-EM buffer pH 8;20 mM Tris pH 8, 150 mM KCl, 2 mM CaCl2, 0.005% GDN, 0.0005% CHS
cryo-EM vitrification conditions Cryogen ETHANE;5 uL of sample was applied to grids at 4 degree temperature with 100% humidity. After 30 seconds, grids were blotted for 5 seconds with blot force 25 and plunged into liquid ethane.
Resolution 3.10 Å
9VU9 channel D complex with 4 Deposited 2025-07-12 Assembly 1 Protein heterocomplex Heteromer;Protein × 7 PDB declaration: heptameric(7) Consistent with protein count
Chain A 1–579(579 aa)
Chain B 1–579(579 aa)
Chain C 1–579(579 aa)
Chain D 1–579(579 aa)
Not recorded A1ETX (3~{S})-3-(1~{H}-benzimidazol-2-ylamino)-~{N}-(cyanomethyl)-~{N}-methyl-3-[3-(trifluoromethyl)phenyl]propanamide × 1 K POTASSIUM ION × 4 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.34 Å
9VUA channel A complex with 1 Deposited 2025-07-12 Assembly 1 Protein heterocomplex Heteromer;Protein × 8 PDB declaration: octameric(8) Consistent with protein count
Chain A 1–579(579 aa)
Chain B 1–579(579 aa)
Chain C 1–579(579 aa)
Chain D 1–579(579 aa)
Not recorded K POTASSIUM ION × 4 POV (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate × 4 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.23 Å
9VUB channel C complex with 3 Deposited 2025-07-12 Assembly 1 Protein heterocomplex Heteromer;Protein × 8 PDB declaration: octameric(8) Consistent with protein count
Chain A 1–579(579 aa)
Chain B 1–579(579 aa)
Chain C 1–579(579 aa)
Chain D 1–579(579 aa)
Not recorded POV (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate × 32 CLR CHOLESTEROL × 8 CA CALCIUM ION × 12 A1B92 Rimtuzalcap × 4 K POTASSIUM ION × 3 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.35 Å
9VUC channel B complex with 2 Deposited 2025-07-12 Assembly 1 Protein heterocomplex Heteromer;Protein × 7 PDB declaration: heptameric(7) Consistent with protein count
Chain A 1–579(579 aa)
Chain B 1–579(579 aa)
Chain C 1–579(579 aa)
Chain D 1–579(579 aa)
Not recorded K POTASSIUM ION × 4 Y7Z UCL1684 × 1 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 2.96 Å
9ZRQ Cryo-EM structure of KCa2.2/calmodulin channel in complex with SKA31. Deposited 2025-12-20 Assembly 1 Protein heterocomplex Heteromer;Protein × 8 PDB declaration: octameric(8) Consistent with protein count
Chain A 117–477(361 aa)
Chain B 117–477(361 aa)
Chain C 117–477(361 aa)
Chain D 117–477(361 aa)
Not recorded K POTASSIUM ION × 4 A1C3Q naphtho[1,2-d][1,3]thiazol-2-amine × 4 CA CALCIUM ION × 8 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 2.77 Å
9ZRR Cryo-EM structure of KCa2.2/calmodulin channel in complex with SKA111. Deposited 2025-12-20 Assembly 1 Protein heterocomplex Heteromer;Protein × 8 PDB declaration: octameric(8) Consistent with protein count
Chain A 117–477(361 aa)
Chain B 117–477(361 aa)
Chain C 117–477(361 aa)
Chain D 117–477(361 aa)
Not recorded K POTASSIUM ION × 2 A1C3U 5-methylnaphtho[1,2-d][1,3]thiazol-2-amine × 4 CA CALCIUM ION × 12 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.31 Å